These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 335935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
    Harris GD, Johnason WG, Nicholson D.
    Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
    Patsche CB, Svensson E, Wejse C.
    Int J Infect Dis; 2014 Sep; 26():88-90. PubMed ID: 25008771
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Two new cases of pulmonary mycobacteriosis due to Mycobacterium xenopi].
    Vayssairat M, Moulias R, Rameix P, Grosset J, Chomette G, Loeper J.
    Ann Med Interne (Paris); 1973 Apr; 124(4):309-12. PubMed ID: 4720416
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
    Bogaerts Y, Elinck W, van Renterghem D, Pauwels R, van der Straeten M.
    Eur J Respir Dis; 1982 Jul; 63(4):298-304. PubMed ID: 7117427
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis.
    Gacad G, Massaro D.
    Am Rev Respir Dis; 1974 Feb; 109(2):274-8. PubMed ID: 4811782
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
    Jenkins PA, Campbell IA, Research Committee of The British Thoracic Society.
    Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
    [Abstract] [Full Text] [Related]

  • 14. [Pulmonary mycobacteriosis due to Mycobacterium battey with favorable development under medical treatment].
    Constans P, Parrot R, Aubriot G, Morin Y, Bariéty M.
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):957-66. PubMed ID: 5402998
    [No Abstract] [Full Text] [Related]

  • 15. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A.
    Z Tuberk Erkr Thoraxorg; 1967 Nov; 127(1):133-40. PubMed ID: 5632190
    [No Abstract] [Full Text] [Related]

  • 16. Activity of certain antibacillary substances in the experimental infection of guinea-pigs exposed to dust by Mycobacterium kansasii.
    Tacquet A, Collet A, Devulder B, Martin JC.
    Z Tuberk Erkr Thoraxorg; 1967 Nov; 127(1):127-31. PubMed ID: 5632591
    [No Abstract] [Full Text] [Related]

  • 17. Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.
    Hoffner SE.
    Eur J Clin Microbiol Infect Dis; 1994 Nov; 13(11):937-41. PubMed ID: 7698120
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Some clinical aspects and treatment of anonymous mycobacterial infections.
    Davey ME.
    Med J Aust; 1967 Sep 02; 2(10):438-41. PubMed ID: 4168734
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.